Medical Advances in Metabiomics™ Clinical Research and Diagnostics
MetaBiomics™ LLC has developed a new microbiomic diagnostics technology for early detection and monitoring of polymicrobial and immunological diseases such as inflammatory bowel disease, colon cancer, HIV infection, alcoholic liver disease, and others that are non-invasive, lower cost, more sensitive and accurate than currently available diagnostic procedures.
For the past 10 years, MetaBiomics™ LLC has been a pioneer in human microbiome research specializing in functional microbiomics and systems biology applied to advances in microbial DNA sequencing methods, clinical research, and in-vitro diagnostics.
Our on-going clinical research is unraveling some of the relationships between human microbiome, immunology, and health. Our research collaborations with the George Mason University's MicroBiome Analysis Center in Manassas, VA, the Rush University Medical Center in Chicago, and other academic research teams are focusing on microbial biomarkers and homeostatic responses in Microbiome Dysbiosis, Colon cancer, Breast cancer, Alcoholic Liver disease, and other diseases impacted by the Human Microbiome.
New Health Sciences Frontiers in Metagenomics and the Human Microbiome
It is not often that health sciences takes off in leaps and bounds on a whole new branch of discovery. Systems Biology scientists are exploring the Metagenome and Microbiome of Humans to map their interactive genetic and metabolic functions.We define the complex Homeostatic interactions of the Human Homobiome and the Human Microbiome as the Human "Metabiome™".
In the human microbiome, microbial cells outnumber human cells by a factor of ten to one. Yet the genomic and metabolic functions of these communities have gone unstudied and their influence upon human development, physiology, immunity, and nutrition is largely unknown. Now, exploiting the DNA sequencing tools developed for the human genome project, the NIH has initiated the Human Microbiome Project (HMP) with the mission of enabling comprehensive characterization of the human microbiota and analysis of its role in human health and disease.
Microbes profoundly shape this planet and all life on it, and this new ability to study in situ microbial communities represents a fundamental shift in microbiology and is one whose implications can only be imagined.
Alliance Partnerships, Licensing, and Research Opportunities
MetaBiomics™ LLC is actively seeking Biotechnology and Biopharmacology alliance partners to accelerate biomarker discovery, clinical research, product development, and clinical trials to explore and map the new frontiers of the Human Metabiome™.
You are invited to contact MetaBiomics™ LLC to explore partnering in the business opportunities outlined on the right.
|
